Caitlyn Fitzpatrick

Patients with the human immunodeficiency virus (HIV) who are also "elite controllers" may hold the answer to the next generation of effective treatments.

For decades researchers have been trying to identify the source of the correlation between rheumatoid arthritis (RA) and fatigue – a common symptom of the disease. However, the reason it may have remained a mystery for so long could be because there isn't one.

Evidence proves that a commonly prescribed drug is able to wipe out multiple potentially deadly antibiotic-resistant infections.

More than 70,000 patients participated in a clinical trial designed to determine the hazard risk of developing psoriatic arthritis (PsA) following physical trauma in patients with psoriasis.

For the first time, a direct biophysical link has been identified that connects chronic pain with mental health and substance abuse.

Although a recent study confirmed that the Ebola virus (EBOV) is no more or less deadly than it was 40 years ago, it has also been confirmed that its progression rate has changed.

Spicy food may hold more power than just adding a little zest to a meal. Researchers have uncovered a key interaction that is responsible for the sensations of pain and heat.

Results from the TECOS trial indicate patients with type 2 diabetes and cardiovascular disease treated with sitagliptin are not at higher risk for cardiovascular events or hospitalization.

Although patients with diabetes who were at high risk for cardiovascular events did not benefit from treatment with lixisenatide, results from the ELIXA study showed that the drug is safe in this population.

Study results show combination treatment with empagliflozin and linagliptin effectively reduced HbA1c in patients with type 2 diabetes mellitus.

When blood glucose levels prove difficult to control in patients with type 2 diabetes mellitus, it may be time to consider adding a third drug to the treatment regimen.

There are a substantial number of factors physicians must take into consideration before starting a patient with type 2 diabetes mellitus on a particular treatment path. According to results from a recent study, the effectiveness of one of the most popular diabetes medications may be dependent on a patient's race or ethnicity.

With multiple factors hurting patients' chances of reaching type 2 diabetes treatment goals – including a lack of timely follow-up appointments and yo-yo blood glucose (A1C) levels – a respected physician recently advised a major shift in treatment, especially early on in the progressive disease.

Even adults with diabetes may be injecting insulin incorrectly which could put them at higher risk for additional conditions, according to lead author Paula M. Trief, PhD, of SUNY Upstate Medical Center.

Pain levels due to diabetic peripheral neuropathy (DPN) may be altered depending on patients' vitamin D levels, a British study. The findings will be presented in a poster session on June 8 at the American Diabetes Association 75th Scientific Sessions in Boston, MA.

Results from a 104-week phase 3 study may have important implications for the way patients with type 2 diabetes mellitus tackle weight loss.

Insulin glargine, a commonly used treatment for type 2 diabetes mellitus, may be more effective when administered at a higher dose, according to results from a phase 3 study.

While medications go through extensive studies and research before being released to patients, the results in a controlled setting versus real-life situations may vary. Or do they?

Study results show that the combination of metformin and glibenclamide is as effective as insulin in achieving glycemic control in women with gestational diabetes and may be a more acceptable and cost effective therapy.

Researchers compared canagliflozin and sitagliptin treatment on HbA1c levels and body weight in patients with type 2 diabetes mellitus.

Approved by the US Food and Drug Administration (FDA) just over 4 years ago, linagliptin (Tradjenta) can help protect against renal injury in patients with type 2 diabetes.

Oxidative stress plays an important role in the ability for dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, to effectively ease diabetic nephropathy, according to lead author Takashi Hatanaka of Nagoya University. The study will be presented in a poster session on June 6 at the American Diabetes Association 75th Scientific Sessions in Boston, MA.

In addition to causing potential damage to the joints, cartilage, ligaments, and bones, osteoarthritis (OA) can lead to sleep disturbances that in turn affect a patient's quality of life.

Why does the human immunodeficiency virus (HIV) envelope protein feature an abnormally long tail when compared to other similar viruses? The reason may finally have been uncovered.

While assessing treatment options for patients with post-traumatic brain injuries, a collaborative team of researchers discovered that oxygen chamber treatment may also benefit patients with fibromyalgia.

While most cases of shingles typically clear up in a matter of a few weeks, the condition has the ability to cause long-term problems.

With certain strains already proving to be resistant to treatment with antibiotics, Staphylococcus aureus is posing another major health threat.

Despite the fact that the Lyme disease-causing bacterium Borrelia burgdorferi does not show antibiotic resistance, the illness continues to prove to be difficult to fight in the late stages.

When a child's pain is more than just a "boo-boo," determining the severity of the pain and a course of action can be extremely challenging.

Patients with venous thromboembolism (VTE) may require a break from warfarin sodium therapy in order to undergo surgery or other procedures, however, a new study addressed if doing so presents too high of a risk.